| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.7B | $-0.0B | $-2.5B | $0.1B | $-1.7B | $-1.3B | $-0.4B | $-1.5B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.1B | $3.2B | $3.4B | $3.9B | $4.3B | $4.5B | $2.4B | $2.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $2.0B | $1.8B | $1.2B | $0.6B | $0.4B | $1.7B | $0.8B | $0.7B |
| Total Liabilities | $0.3B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.7B | $3.0B | $3.3B | $3.9B | $4.2B | $4.5B | $2.4B | $1.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.2B | $0.2B | $-1.3B | $0.8B | $-3.3B | $-1.3B | $-0.8B | $0.2B |
| Investing Cash Flow | — | — | — | — | — | — | — | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.9B | $-0.2B | $1.9B | $-0.4B | $1.4B | $3.4B | $0.9B | $0.4B |